The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Abel Douglas since year 2005.
The trader's CIK number is 1324106.
At the time of this reporting, Abel Douglas is the President and CEO of Manhattan Pharmaceuticals Inc .
(stock ticker symbol MHTT).
See this page for all insider trading activities at Manhattan Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2006-07-10||MHA||Manhattan Pharmaceuticals Inc||Buy||5,000||.75||3,750|
|2005-11-18||MHA||Manhattan Pharmaceuticals Inc||Buy||5,000||1.28||6,400|
|2005-10-21||MHTT||Manhattan Pharmaceuticals Inc||Buy||5,000||1.31||6,550|
|2005-10-20||MHTT||Manhattan Pharmaceuticals Inc||Buy||5,000||1.29||6,465|
|2005-04-26||MHTT||Manhattan Pharmaceuticals Inc||Buy||2,500||1.42||3,550|
|2005-04-25||MHTT||Manhattan Pharmaceuticals Inc||Buy||5,000||1.50||7,500|
|2005-04-21||MHTT||Manhattan Pharmaceuticals Inc||Buy||2,500||1.53||3,825|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Abel Douglas (President and CEO of Manhattan Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.